» Articles » PMID: 32902275

Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties

Abstract

Lactate dehydrogenase (LDH) catalyzes the conversion of pyruvate to lactate, with concomitant oxidation of reduced nicotinamide adenine dinucleotide as the final step in the glycolytic pathway. Glycolysis plays an important role in the metabolic plasticity of cancer cells and has long been recognized as a potential therapeutic target. Thus, potent, selective inhibitors of LDH represent an attractive therapeutic approach. However, to date, pharmacological agents have failed to achieve significant target engagement , possibly because the protein is present in cells at very high concentrations. We report herein a lead optimization campaign focused on a pyrazole-based series of compounds, using structure-based design concepts, coupled with optimization of cellular potency, drug-target residence times, and PK properties, to identify first-in-class inhibitors that demonstrate LDH inhibition . The lead compounds, named () and (), possess desirable attributes for further studying the effect of LDH inhibition.

Citing Articles

Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma.

Wang K, Li X, Guo S, Chen J, Lv Y, Guo Z Front Oncol. 2025; 15:1545086.

PMID: 39980550 PMC: 11839411. DOI: 10.3389/fonc.2025.1545086.


Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy.

Pyrczak-Felczykowska A, Herman-Antosiewicz A Int J Mol Sci. 2025; 26(3).

PMID: 39941144 PMC: 11818413. DOI: 10.3390/ijms26031376.


Experimental, Theoretical, and Studies of Potential CDC7 Kinase Inhibitors.

Byadarahalli Ravindranath K, Kandasamy S, Ebaid H, Al-Tamimi J, Talya Narasimhamurthy S, Nagaraja M ACS Omega. 2025; 10(1):609-618.

PMID: 39829445 PMC: 11740380. DOI: 10.1021/acsomega.4c07221.


Synthesis of Ethyl Pyrimidine-Quinolincarboxylates Selected from Virtual Screening as Enhanced Lactate Dehydrogenase (LDH) Inhibitors.

Diaz I, Salido S, Nogueras M, Cobo J Int J Mol Sci. 2024; 25(17).

PMID: 39273691 PMC: 11396203. DOI: 10.3390/ijms25179744.


Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy.

Masci D, Puxeddu M, Silvestri R, La Regina G Molecules. 2024; 29(9).

PMID: 38731601 PMC: 11085455. DOI: 10.3390/molecules29092110.


References
1.
Sheng S, Liu J, Dai Y, Sun X, Xiong X, Huang G . Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J. 2012; 279(20):3898-910. DOI: 10.1111/j.1742-4658.2012.08748.x. View

2.
Xie H, Hanai J, Ren J, Kats L, Burgess K, Bhargava P . Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab. 2014; 19(5):795-809. PMC: 4096909. DOI: 10.1016/j.cmet.2014.03.003. View

3.
Le A, Cooper C, Gouw A, Dinavahi R, Maitra A, Deck L . Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A. 2010; 107(5):2037-42. PMC: 2836706. DOI: 10.1073/pnas.0914433107. View

4.
Fantin V, St-Pierre J, Leder P . Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006; 9(6):425-34. DOI: 10.1016/j.ccr.2006.04.023. View

5.
Pohida K, Maloney D, Mott B, Rai G . Room-Temperature, Copper-Free Sonogashira Reactions Facilitated by Air-Stable, Monoligated Precatalyst [DTBNpP] Pd(crotyl)Cl. ACS Omega. 2019; 3(10):12985-12998. PMC: 6644404. DOI: 10.1021/acsomega.8b01868. View